Internal Medicine, Hematology & Oncology · Murfreesboro, TN
NPI
1518919000
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1840 Medical Center Pkwy, Ste 300
Murfreesboro, TN, 37129
Phone (615) 848-0488
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
177,538 services
Medicare patients, 2024
500
Average age 74
Drug cost, 2024
$5.6M
922 prescriptions
Company payments, 2025
$2,590
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D Zubkus was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 27,060 times for 27 patients. In total John D Zubkus billed 177,538 services in 173 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 27,060 | 27 | $2.32 | $63K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 21,000 | 15 | $0.85 | $18K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,400 | 16 | $16.13 | $39K |
| J0897 Injection, denosumab, 1 mg | Office | 2,160 | 27 | $20.48 | $44K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,008 | 55 | $0.09 | $175 |
| 85025 Blood Count | Office | 1,698 | 395 | $7.55 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,440 | 402 | $8.59 | $12K |
| 80053 Clinical Chemistry | Office | 1,360 | 393 | $10.30 | $14K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 430 | 13 | $0.71 | $307 |
| 99214 Office E&M - Established | Office | 426 | 251 | $86.39 | $37K |
| J9045 Injection, carboplatin, 50 mg | Office | 413 | 15 | $2.71 | $1,119 |
| 99215 Office E&M - Established | Office | 384 | 100 | $127.01 | $49K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 358 | 61 | $71.23 | $25K |
| 96367 Intravenous Infusion, Hydration | Office | 321 | 60 | $19.10 | $6,130 |
| 96413 Chemotherapy Administration | Office | 314 | 64 | $89.57 | $28K |
By year: 2022 $2.6M for 216,232 services; 2023 $2.3M for 178,324 services; 2024 $3.0M for 177,538 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,698 | 395 | $7.55 | $13K |
| 36415 Venipuncture Blood Collection | 1,440 | 402 | $8.59 | $12K |
| 80053 Clinical Chemistry | 1,360 | 393 | $10.30 | $14K |
| 82784 Immunoassay | 284 | 38 | $9.11 | $2,588 |
| 82728 Clinical Chemistry | 251 | 119 | $13.33 | $3,346 |
| 83540 Clinical Chemistry | 247 | 118 | $6.32 | $1,562 |
| 83550 Clinical Chemistry | 246 | 117 | $8.55 | $2,103 |
| 83615 Clinical Chemistry | 181 | 72 | $5.86 | $1,061 |
| 83521 Immunoassay | 166 | 29 | $16.50 | $2,738 |
| 84443 Clinical Chemistry | 137 | 36 | $16.46 | $2,255 |
Medicare prescription drug claims, 2024
In 2024, the drug John D Zubkus prescribed most often to Medicare patients was Letrozole, with 103 prescriptions and refills. In total John D Zubkus wrote 922 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 103 | 205 | 29 | $2,071 |
| Revlimid Lenalidomide | 83 | 83 | Under 11 | $1.2M |
| Dexamethasone Generic | 68 | 68 | 12 | $833 |
| Acyclovir Generic | 54 | 54 | 12 | $495 |
| Xtandi Enzalutamide | 51 | 51 | Under 11 | $618K |
| Prochlorperazine Maleate Generic | 43 | 43 | 33 | $441 |
| Venclexta Venetoclax | 41 | 41 | Under 11 | $451K |
| Ibrance Palbociclib | 29 | 29 | Under 11 | $457K |
| Tamoxifen Citrate Generic | 23 | 39 | Under 11 | $550 |
| Pomalyst Pomalidomide | 23 | 23 | Under 11 | $446K |
| Xarelto Rivaroxaban | 22 | 38 | Under 11 | $21K |
| Ondansetron Odt Ondansetron | 21 | 21 | 17 | $276 |
| Levothyroxine Sodium Generic | 21 | 32 | Under 11 | $41.17 |
| Hydroxyurea Generic | 18 | 23 | Under 11 | $267 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 16 | 16 | 13 | $198 |
Brand drugs: 464 claims; generic drugs: 458 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D Zubkus $2,590 ($2,590 in general payments such as food, travel and fees) from 37 companies. The largest payer was Novartis Pharmaceuticals Corporation with $213.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $213 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $208 |
| Adc Therapeutics America, Inc. | 3 | $187 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $167 |
| GlaxoSmithKline, LLC. GSK | 4 | $148 |
| Kite Pharma, Inc. GILD | 1 | $147 |
| Stemline Therapeutics Inc. | 2 | $143 |
| Merck Sharp & Dohme LLC MRK | 5 | $138 |
| Astellas Pharma US Inc 4503.T | 4 | $104 |
| Daiichi Sankyo Inc. 4568.T | 3 | $77.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.